Skip to main content

Longaeva Partners L.P.

Source: SEC Form 13F · as of Mar 2026

Longaeva Partners L.P. holds 38 biotech & pharma companies tracked by BioSniper, totaling $259.2M in value as of Mar 2026 (SEC Form 13F).

Companies held

38

Total value held

$259.2M

BioSniper AIPage evidence connected

Prepared research question

What matters most for PFIZER INC (PFE)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PFEPFIZER INC1,040,615$29.2M
LNTHLantheus Holdings, Inc.383,945$29.1M
NRIXNurix Therapeutics, Inc.1,490,202$23.1M
AZNASTRAZENECA PLC80,130$15.8M
COGTCogent Biosciences, Inc.335,000$12.9M
ARWRARROWHEAD PHARMACEUTICALS, INC.194,589$12.2M
VRTXVERTEX PHARMACEUTICALS INC / MA24,935$11.1M
BNTXBioNTech SE119,204$10.6M
QGENQIAGEN N.V.230,000$9.2M
IMTXImmatics N.V.780,967$7.7M
MLTXMoonLake Immunotherapeutics410,000$7.6M
INSPInspire Medical Systems Inc.138,761$7.2M
SVRASavara Inc1,275,000$7.0M
AMGNAMGEN INC19,413$6.8M
ORKAOruka Therapeutics, Inc.136,884$6.7M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.36,721$6.3M
UNHUnitedHealth Group Incorporated Common Stock (DE)20,000$5.4M
BLTEBELITE BIO, INC33,492$5.3M
RAREUltragenyx Pharmaceutical Inc.228,107$4.8M
RLAYRelay Therapeutics, Inc.470,544$4.7M
ELVNEnliven Therapeutics, Inc.113,065$4.4M
PRCTPROCEPT BioRobotics Corporation175,000$4.4M
VSTMVerastem, Inc.807,755$4.3M
ANNXAnnexon, Inc.620,401$3.4M
ERASErasca, Inc.171,233$2.8M
CGEMCullinan Therapeutics, Inc.183,691$2.6M
TRDAEntrada Therapeutics, Inc.204,978$2.6M
CTMXCytomX Therapeutics, Inc.550,000$2.6M
SEPNSepterna, Inc.74,567$1.8M
CLYMClimb Bio, Inc.217,768$1.5M
BNTCBenitec Biopharma Inc.125,000$1.3M
EWTXEdgewise Therapeutics, Inc.36,931$1.2M
SMMTSummit Therapeutics Inc.57,282$1.1M
PMVPPMV Pharmaceuticals, Inc.552,027$685K
ARVNARVINAS, INC.50,205$532K
SIONSionna Therapeutics, Inc.12,693$509K
BEAMBeam Therapeutics Inc.15,518$370K
XENEXenon Pharmaceuticals Inc.6,250$363K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.